StrokeNCT06057753
MyStroke in Chronic Stroke
A study testing MyStroke in people with Stroke, run by University of Pennsylvania at 1 site in United States.
Trial summary
This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stroke
- What is being tested?
- MyStroke
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Oct 2023to Apr 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- History of ischemic stroke between 1 and 10 years prior to enrollment
- Receiving outpatient stroke care at the Hospital of the University of Pennsylvania
- At least 18 years old
- Access to a smart phone, tablet, or computer
- Willingness to complete 2 follow-up surveys (7 days and 90 day post-enrollment)
Who cannot join
- Unwilling or unable to access the customized app with a smartphone, tablet, or computer
- Complete dependence on caregiver for all activities of daily living
- Stroke occurred less than 1 year or greater than 10 years prior to screening/enrollment
- Patient has severe aphasia (score of greater than or equal to 2 on National Institutes of Health Stroke Scale item 9)
Trial locations and contacts
1 site in 1 country.
United States1 site
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
About this study
Official title: Personalized Video-based Education for Chronic Stroke Survivors: A Randomized Clinical Trial
This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.
- Conditions
- Stroke
- Being tested
- MyStroke
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MyStrokeBehavioural
Personalized video-based stroke education platform
| Study group | Role | What they receive |
|---|---|---|
| Standard Education | No intervention | Standard stroke patient education as per the medical providers |
| MyStroke | Experimental | Access to a personalized video-based stroke educational platform Receives: Behavioral: MyStroke |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient satisfaction with stroke education (90 days)
5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)
Measured: 90 days
Stroke etiology recognition (90 days)
The proportion of patients who correctly identify their stroke etiology
Measured: 90 days
Stroke risk factor recognition (90 days)
The proportion of patients who correctly identify at least one of their vascular risk factors
Measured: 90 days
Secondary outcomes (12)
Stroke prevention medication recognition (7 days)
The proportion of patients who correctly identify their antithrombotic medications
Measured: 7 days
Stroke prevention medication recognition (90 days)
The proportion of patients who correctly identify their antithrombotic medications
Measured: 90 days
Patient satisfaction with stroke education (7 days)
5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)
Measured: 7 days
Stroke etiology recognition (7 days)
The proportion of patients who correctly identify their stroke etiology
Measured: 7 days
Stroke risk factor recognition (7 days)
The proportion of patients who correctly identify at least one of their vascular risk factors
Measured: 7 days
Stroke patient education retention (SPER) survey (7 days)
total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)
Measured: 7 days
Stroke patient education retention (SPER) survey (90 days)
total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)
Measured: 90 days
EuroQOL - visual analog scale (7 days)
patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)
Measured: 7 days
EuroQOL - visual analog scale (90 days)
patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)
Measured: 90 days
modified Rankin Scale
Ordinal functional disability scale (score 0 - 6)
Measured: 90 days
Medication adherence (7 days)
total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)
Measured: 7 days
Medication adherence (90 days)
total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)
Measured: 90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2023
- Study start17 Oct 2023
- Primary completion15 Oct 2024
- Study completionApr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by University of PennsylvaniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Christopher Favilla, University of Pennsylvania
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06057753
- Sponsor's protocol ID
- 854145
- Status last verified
- Feb 2026
- First submitted
- 22 Aug 2023
- Last updated
- 13 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Personalized Video-based Education for Chronic Stroke Survivors: A Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT06057753
- Acronym / sponsor ID
- 854145
- Conditions
- Stroke
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University of PennsylvaniaUniversity, hospital or other
- Study start
- 17 Oct 2023 (actual)
- Primary completion
- 15 Oct 2024 (actual)
- Study completion
- Apr 2026 (estimated)
- First posted
- 28 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Standard Education | No intervention | –Standard stroke patient education as per the medical providers |
| MyStroke | Experimental | Behavioral: MyStrokeAccess to a personalized video-based stroke educational platform |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- History of ischemic stroke between 1 and 10 years prior to enrollment
- Receiving outpatient stroke care at the Hospital of the University of Pennsylvania
- At least 18 years old
- Access to a smart phone, tablet, or computer
- Willingness to complete 2 follow-up surveys (7 days and 90 day post-enrollment)
Key exclusion criteria (4 listed)
- Unwilling or unable to access the customized app with a smartphone, tablet, or computer
- Complete dependence on caregiver for all activities of daily living
- Stroke occurred less than 1 year or greater than 10 years prior to screening/enrollment
- Patient has severe aphasia (score of greater than or equal to 2 on National Institutes of Health Stroke Scale item 9)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MyStrokePersonalized video-based stroke education platform | Behavioural | MyStroke |
Primary outcome
Patient satisfaction with stroke education (90 days)
Time frame: 90 days
5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)
Stroke etiology recognition (90 days)
Time frame: 90 days
The proportion of patients who correctly identify their stroke etiology
Stroke risk factor recognition (90 days)
Time frame: 90 days
The proportion of patients who correctly identify at least one of their vascular risk factors
12 secondary outcomes
Stroke prevention medication recognition (7 days)
Time frame: 7 days
Stroke prevention medication recognition (90 days)
Time frame: 90 days
Patient satisfaction with stroke education (7 days)
Time frame: 7 days
Stroke etiology recognition (7 days)
Time frame: 7 days
Stroke risk factor recognition (7 days)
Time frame: 7 days
Stroke patient education retention (SPER) survey (7 days)
Time frame: 7 days
Stroke patient education retention (SPER) survey (90 days)
Time frame: 90 days
EuroQOL - visual analog scale (7 days)
Time frame: 7 days
EuroQOL - visual analog scale (90 days)
Time frame: 90 days
modified Rankin Scale
Time frame: 90 days
Medication adherence (7 days)
Time frame: 7 days
Medication adherence (90 days)
Time frame: 90 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2026.
Related trials for Stroke
Recruiting
Connectomic Alterations Following Acute Ischemic Stroke in the MCA Territory
Ischemic Stroke
RecruitingObservational study
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
Active, not recruitingPhase 4
A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
Ischemic Stroke Hospitalized, Impairment, Cognitive
Not yet recruitingPhase 4
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
Ischemic Stroke
RecruitingObservational study
CoMind Early Feasibility Study
Intracranial Pressure, Intracranial Pressure Changes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing MyStroke in people with Stroke, run by University of Pennsylvania at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient satisfaction with stroke education (90 days) (time frame: 90 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.